NantHealth, Inc. (NHIQ) Aktienanalyse

NantHealth, Inc. (NHIQ) Gesundheitswesen & Pipeline-Uebersicht

NantHealth, Inc. delivers SaaS-based clinical decision support and data solutions to healthcare providers and payers, focusing on oncology and network monitoring. Their Eviti platform and NaviNet solutions aim to improve care coordination and streamline administrative processes within the complex healthcare ecosystem, operating primarily in the US, Canada, and the UK.

Investmentthese

NantHealth, Inc. operates in the healthcare IT sector, which is experiencing growth due to the increasing need for efficient data management and care coordination. The company's Eviti platform and NaviNet solutions address these needs, particularly in the oncology space. However, with a market capitalization of $0.00B and a negative P/E ratio, the company's financial performance raises concerns. A gross margin of 57.0% indicates some operational efficiency, but a profit margin of -101.2% suggests significant challenges in achieving profitability. Key value drivers include expanding the adoption of Eviti and NaviNet solutions, securing new partnerships with payers and providers, and demonstrating improved financial performance. The high beta of -5.74 suggests high volatility. Investors should carefully consider the company's financial stability and growth prospects before investing.

Basierend auf FMP-Finanzdaten und quantitativer Analyse

Wichtige Highlights

• Market Cap of $0.00B indicates a micro-cap company with high growth potential but also higher risk.
• Gross Margin of 57.0% demonstrates the potential for profitability if operating expenses are managed effectively.
• Profit Margin of -101.2% signals significant challenges in achieving profitability and requires close monitoring.
• Beta of -5.74 suggests the stock price moves inversely and more drastically than the market, indicating high volatility.
• Offers SaaS based solutions - clinical decision support and network monitoring - which can lead to recurring revenue streams.

Wettbewerber & Vergleichsunternehmen

Staerken

• Comprehensive Eviti platform for cancer treatment decision support.
• NaviNet platform for streamlined payer-provider communication.
• SaaS-based business model providing recurring revenue.
• Established presence in the US, Canada, and the UK.

Schwaechen

• Negative profit margin indicating financial challenges.
• High beta suggesting high stock price volatility.
• Limited market capitalization compared to larger competitors.
• Dependence on NantWorks, LLC for resources and support.

Katalysatoren

• Ongoing: Expansion of the Eviti platform to cover additional cancer types and treatment modalities.
• Ongoing: Strategic partnerships with major health insurance companies to integrate NaviNet.
• Upcoming: Potential geographic expansion into European markets.
• Upcoming: Development and launch of AI-powered analytics for the Quadris data solution.
• Ongoing: Integration of Eviti and NaviNet solutions with telehealth platforms.

Risiken

• Ongoing: Intense competition from larger healthcare IT companies.
• Potential: Changes in healthcare regulations and reimbursement policies.
• Potential: Data security and privacy concerns.
• Potential: Technological obsolescence.
• Ongoing: Negative profit margin and financial challenges.

Wachstumschancen

• Expansion of Eviti Platform: NantHealth has the opportunity to expand the capabilities of its Eviti platform to cover a broader range of cancer types and treatment modalities. By incorporating the latest research and clinical guidelines, Eviti can become an even more valuable tool for oncologists, driving increased adoption and revenue growth. The market for oncology clinical decision support systems is projected to reach $1.5 billion by 2028, presenting a significant opportunity for NantHealth to capture a larger share.
• Strategic Partnerships with Payers: Collaborating with major health insurance companies to integrate NaviNet into their existing systems can streamline pre-authorization processes and improve communication with providers. This can lead to increased efficiency and cost savings for payers, making NaviNet an attractive solution. The market for payer-provider communication platforms is estimated at $2.2 billion, offering substantial growth potential for NantHealth through strategic partnerships.
• Geographic Expansion into Europe: Expanding its operations into European markets, where healthcare systems are increasingly focused on digitization and value-based care, represents a significant growth opportunity for NantHealth. By adapting its Eviti and NaviNet solutions to meet the specific needs of European healthcare providers and payers, NantHealth can tap into a new revenue stream. The European healthcare IT market is projected to reach $80 billion by 2027.
• Development of AI-Powered Analytics: Incorporating artificial intelligence (AI) and machine learning (ML) into its Quadris data solution can enable NantHealth to provide more advanced analytics and insights to healthcare providers and payers. This can help them identify trends, predict outcomes, and optimize treatment strategies. The market for AI in healthcare is projected to reach $45 billion by 2026, presenting a significant opportunity for NantHealth to leverage its data assets and expertise.
• Integration with Telehealth Platforms: Integrating its Eviti and NaviNet solutions with telehealth platforms can enable NantHealth to extend its reach and provide its services to a wider range of patients and providers. This can be particularly valuable in rural areas and underserved communities, where access to specialized healthcare services may be limited. The telehealth market is projected to reach $175 billion by 2026, offering a substantial growth opportunity for NantHealth through strategic integrations.

Chancen

• Expansion of Eviti platform to cover more cancer types.
• Strategic partnerships with major health insurance companies.
• Geographic expansion into European markets.
• Development of AI-powered analytics for Quadris data solution.

Risiken

• Intense competition from larger healthcare IT companies.
• Changes in healthcare regulations and reimbursement policies.
• Data security and privacy concerns.
• Potential for technological obsolescence.

Wettbewerbsvorteile

• Proprietary Technology: Eviti's comprehensive library of evidence-based treatment standards and protocols provides a competitive advantage.
• Established Relationships: Long-standing relationships with payers and providers create switching costs.
• Data Network Effects: The more users on the NaviNet platform, the more valuable it becomes for all participants.

Ueber NHIQ

NantHealth, Inc., established in 2010 and headquartered in Morrisville, North Carolina, is a healthcare IT company operating in the United States, Canada, and the United Kingdom. As a subsidiary of NantWorks, LLC, NantHealth provides a suite of software and data solutions designed to improve healthcare delivery and administrative efficiency. The company's core offerings include the Eviti platform, a SaaS-based clinical decision support system that centralizes clinical content, treatment cost data from Medicare reimbursements, and treatment toxicity data. Eviti Connect leverages this platform to automate pre-authorization processes, assisting payers and providers in navigating the complexities of cancer care. Additionally, Eviti Advisor allows physicians to access the Eviti platform's comprehensive library of evidence-based treatment standards and protocols to inform treatment decisions. NantHealth also offers NaviNet, a suite of SaaS-based solutions that streamline communication and consolidate information between payers and providers. NaviNet Open serves as a payer-provider collaboration platform, while NaviNet AllPayer provides eligibility, benefit, and claim status information to provider offices for commercial and government plans, including Medicare beneficiaries. Furthermore, NantHealth provides OpenNMS, an open-source network monitoring solution for enterprise-grade networks, and Quadris, a data solution that includes multi-data analysis, reporting, and professional services. Originally known as Nant Health, LLC, the company changed its name to NantHealth, Inc. in June 2016.

Was das Unternehmen tut

• Offers Eviti, a SaaS-based clinical decision support solution for cancer treatment.
• Provides Eviti Connect, automating pre-authorization for cancer care.
• Offers Eviti Advisor, giving physicians access to evidence-based treatment standards.
• Delivers NaviNet, a suite of SaaS solutions for payer-provider communication.
• Provides NaviNet Open, a platform for collaboration between health plans and providers.
• Offers NaviNet AllPayer, providing eligibility and claim status information.
• Provides OpenNMS, an open-source network monitoring solution.
• Offers Quadris, a data solution for multi-data analysis and reporting.

Geschaeftsmodell

• Software-as-a-Service (SaaS): Generates recurring revenue through subscriptions to its Eviti and NaviNet platforms.
• Data Solutions: Provides data analysis, reporting, and professional services through its Quadris solution.
• Platform Integration: Earns revenue by integrating its solutions with payer and provider systems.

Branchenkontext

NantHealth, Inc. operates within the healthcare IT sector, a market driven by the increasing adoption of electronic health records (EHRs), the growing need for interoperability, and the rising demand for data analytics solutions. The industry is characterized by intense competition, with established players like ACHKF (Allscripts Healthcare Solutions) and ALDNF (Cerner Corporation) vying for market share. NantHealth's focus on oncology and payer-provider communication positions it within specific niches of this broader market. The healthcare IT market is projected to continue growing, fueled by government initiatives promoting healthcare digitization and the increasing prevalence of chronic diseases.

Wichtige Kunden

• Healthcare Providers: Oncologists, hospitals, and clinics use Eviti to support treatment decisions.
• Health Insurance Companies: Payers use NaviNet to streamline communication and pre-authorization processes.
• Enterprise-Grade Networks: Organizations use OpenNMS for network monitoring.

Finanzdaten

Chart & Info

Aktuelle Nachrichten

Keine aktuellen Nachrichten fuer NHIQ verfuegbar.

Analystenkonsens

MoonshotScore

Haeufige Fragen zu NHIQ

Haftungsausschluss: Dieser Inhalt dient ausschliesslich zu Informationszwecken und stellt keine Anlageberatung dar. Fuehren Sie immer Ihre eigene Recherche durch und konsultieren Sie einen Finanzberater.

Offizielle Ressourcen

Popular Stocks